Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human disease.
Brandstadter JD, De Martin A, Lütge M, Ferreira A, Gaudette BT, Stanossek Y, Wang S, Gonzalez MV, Camiolo E, Wertheim G, Austin B, Allman D, Lim MS, Fajgenbaum DC, Aster JC, Ludewig B, Maillard I. Brandstadter JD, et al. Among authors: fajgenbaum dc. bioRxiv [Preprint]. 2023 Feb 7:2023.02.06.525604. doi: 10.1101/2023.02.06.525604. bioRxiv. 2023. Update in: Eur J Immunol. 2023 Sep;53(9):e2250362. doi: 10.1002/eji.202250362 PMID: 36798373 Free PMC article. Updated. Preprint.
CRP and sCD25 help distinguish between adult-onset Still's disease and HLH.
Beckett M, Spaner C, Goubran M, Wade J, Avina-Zubieta JA, Setiadi A, Tucker L, Shojania K, Au S, Mattman A, Lee AYY, Fajgenbaum DC, Chen LYC. Beckett M, et al. Among authors: fajgenbaum dc. Eur J Haematol. 2024 Nov;113(5):576-583. doi: 10.1111/ejh.14267. Epub 2024 Jul 10. Eur J Haematol. 2024. PMID: 38984483
Castleman Disease Pathogenesis.
Fajgenbaum DC, Shilling D. Fajgenbaum DC, et al. Hematol Oncol Clin North Am. 2018 Feb;32(1):11-21. doi: 10.1016/j.hoc.2017.09.002. Hematol Oncol Clin North Am. 2018. PMID: 29157613 Review.
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, Munshi N, Schey S, Streetly M, Pierson SK, Partridge HL, Mukherjee S, Shilling D, Stone K, Greenway A, Ruth J, Lechowicz MJ, Chandrakasan S, Jayanthan R, Jaffe ES, Leitch H, Pemmaraju N, Chadburn A, Lim MS, Elenitoba-Johnson KS, Krymskaya V, Goodman A, Hoffmann C, Zinzani PL, Ferrero S, Terriou L, Sato Y, Simpson D, Wong R, Rossi JF, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Oksenhendler E, Fajgenbaum DC. van Rhee F, et al. Among authors: fajgenbaum dc. Blood. 2018 Nov 15;132(20):2115-2124. doi: 10.1182/blood-2018-07-862334. Epub 2018 Sep 4. Blood. 2018. PMID: 30181172 Free PMC article.
Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial data.
Morra DE, Pierson SK, Shilling D, Nemat S, Appiani C, Guilfoyle M, Tendler C, van Rhee F, Fajgenbaum DC. Morra DE, et al. Among authors: fajgenbaum dc. Br J Haematol. 2019 Jan;184(2):232-241. doi: 10.1111/bjh.15588. Epub 2018 Sep 11. Br J Haematol. 2019. PMID: 30203839 Free PMC article. Clinical Trial.
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.
Nabel CS, Sameroff S, Shilling D, Alapat D, Ruth JR, Kawano M, Sato Y, Stone K, Spetalen S, Valdivieso F, Feldman MD, Chadburn A, Fosså A, van Rhee F, Lipkin WI, Fajgenbaum DC. Nabel CS, et al. Among authors: fajgenbaum dc. PLoS One. 2019 Jun 26;14(6):e0218660. doi: 10.1371/journal.pone.0218660. eCollection 2019. PLoS One. 2019. PMID: 31242229 Free PMC article.
101 results